Feb 2, 2017
WiseGuyReports.com adds Exclusive Research on “Oxford Immunotec Ltd - Product Pipeline Analysis, 2016 Update” reports to its database.
Pune, India - February 2, 2017 /MarketersMedia/ —
Summary
Oxford Immunotec Ltd (Oxford Immunotec) is a medical device company that develops and commercializes proprietary tests. The company provides international T cell measurement products including T-Cell Xtend and T-SPOT. Its T-SPOT.TB test diagnoses both latent TB infection and active disease by measuring T cells that have been activated by Mycobacterium tuberculosis antigens. Oxford Immunotec’s T-SPOT.CMV is a factor in controlling viral latency and vulnerability to CMV disease. The company’s T-Cell Xtend reagent is an antibody complex added to blood samples in the laboratory before running the T-SPOT.TB assay. Its T-SPOT solution offers diagnosing disease by providing a method of measuring immune response to an infection. The company markets its products in the US, several European countries and Japan. Oxford Immunotec is headquartered in Abingdon, the UK.
GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/918681-oxford-immunotec-ltd-product-pipeline-analysis-2016-update
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Oxford Immunotec Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Content: Key Points
Table of Contents 2
List of Tables 4
List of Figures 5
Oxford Immunotec Ltd Company Overview 6
Oxford Immunotec Ltd Company Snapshot 6
Oxford Immunotec Ltd Pipeline Products and Clinical Trials Overview 7
Oxford Immunotec Ltd – Pipeline Analysis Overview 9
Key Facts 9
Oxford Immunotec Ltd - Major Products and Services 10
Oxford Immunotec Ltd Pipeline Products by Development Stage 11
Oxford Immunotec Ltd Pipeline Products Overview 15
B Cell ELISPOT Assay 15
B Cell ELISPOT Assay Product Overview 15
GoutiFind Test 16
GoutiFind Test Product Overview 16
I-O Monitoring Test 17
I-O Monitoring Test Product Overview 17
Metabovis Assay - Homocysteine 18
…Continued
ACCESS REPORT @ https://www.wiseguyreports.com/reports/918681-oxford-immunotec-ltd-product-pipeline-analysis-2016-update
Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts
Contact Info:
Name: Norah Trent
Organization: WiseGuy Reports
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune - 411028 Maharashtra, India
Phone: +1-646-845-9349
Source URL: http://marketersmedia.com/oxford-immunotec-ltd-pharmaceutical-and-healthcare-pipeline-review-h2/166555
For more information, please visit http://www.wiseguyreports.com
Source: MarketersMedia
Release ID: 166555
Beyoncé and Jay-Z love this evening like XO. After all, the couple was drunk on love while celebrating the 20th anniversary of the "Empire State of Mind" rapper's champagne brand Ace of Spades...
After a five-year hiatus, Sarah J. Maas returns with the latest installment in her best-selling romantasy series.
The singer, 37, had pleaded guilty after hitting a music producer repeatedly in the head with a bottle in London in 2023. He is unlikely to serve any prison time.
“Star Wars” fans are getting a closer look at how Din Djarin and Grogu made the jump from Disney+ to the big screen. “The Art of Star Wars: The Mandalorian and Grogu,” a new 256-page hardcover from Abrams Books, arrives Nov. 3, offering an inside look at the creative process behind Lucasfilm’s latest theatrical release. […]
Matthew Judon’s family is including everyone in their huddle. The San Francisco 49ers defensive lineman’s ex-girlfriend Arabia Tillery recently shared a play by play into the NFL star’s...
NewFilmmakers Los Angeles has announced four new board members and forged a strategic partnership in the United Arab Emirates with the Sharjah Intl. Film Festival for Children and Youth. Joining the board of directors of the non-profit arts and culture organization that is focused on championing independent filmmakers and content creators are: Beverly Hills-based entertainment […]
“You Can See Everything” has remained a must-see at the box office, collecting a remarkable $19.5 million from 2,655 theaters in its second weekend — a notable increase in ticket sales from its sizable opening. A24’s buzzy documentary about Theranos fraudster Elizabeth Holmes has grossed $45.1 million domestically to date and will be wildly profitable […]
Anthropic spent much of its filing with the SEC ahead of its initial public offering warning potential investors about the risks its AI models could pose to humanity, acknowledging it could not entirely ensure its own safety measures would be successful against the “existential” danger AI could pose. The disclosures came as part of more than […]
Director Ania Winiarska almost gave up on “Good Girls.” “After six months, I felt like I’d hit a wall. I’ve never had this problem before,” she told Variety. “It was always very natural for me to gain people’s trust, but my previous films were about boys or men. This one was about teenage girls and […]
With all due respect to Taylor Swift's guy on the Chiefs and the major NFL plays that left the dads, Brads and Chads screaming, the most important stat of the weekend came when news broke that Tom...
Robert Pattinson is sharing a new update on The Batman Part II as filming gets back underway following a temporary […] The post Robert Pattinson Reveals When He’s Returning to ‘The Batman Part II’ Set, Reacts to Steven Soderbergh Taking Over Filming appeared first on Just Jared - Celebrity News, Entertainment News & Photos.
Lindsay Hubbard's latest summer lovin' is making quite the splash in the Bravo-verse. Following weeks of speculation she and Below Deck Mediterranean's Joe Bradley are dating, the Summer...
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.